Reported segment mix · SEC DERA dimensional facts

NOVAVAX INC NVAX revenue by segment, product and geography

In its fiscal year ending 2025-12-31, NOVAVAX INC reported revenue across 1 business segments; the largest, Reportable Segment, was $1.12B, 100.0% of the filed sum (+64.7% against the prior period in the same filing).

Full financial analysis →Company overview →

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing

Fiscal year ending 2025-12-3110-K filed 2026-02-26prior period 2024-12-31 from the same filingView filing

By business segment

Revenue

Reportable Segment$1.12B
100.0%
+64.7% yoy

Members sum to the consolidated $1.12B for this period.

By product or service

Revenue

Product$685M
share n/a
+221.3% yoy
Nuvaxovid Sales$625M
share n/a
+228.7% yoy
Licensing Royalties And Other$438M
share n/a
-6.5% yoy
Supply Sales$59.9M
share n/a
+160.4% yoy
Grant$0
share n/a
no prior

member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.

By geography

Revenue

Rest Of North America$576M
51.2%
+12801.6% yoy
United States$406M
36.1%
-22.4% yoy
Rest Of The World$126M
11.3%
+114.3% yoy
Europe$15.7M
1.4%
-83.6% yoy

Members sum to the consolidated $1.12B for this period.

Latest quarter

Quarter ending 2026-03-3110-Q filed 2026-05-06prior period 2025-03-31 from the same filingView filing

Reportable Segment$140M
100.0%
-79.1% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

About these figures

Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.

Descriptive and educational; not investment advice. Methodology and data lineage.